LFM
XBIT icon

LGT Fund Management’s XBiotech XBIT Stock Holding History

LGT Fund Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$39.7K – 144
2023
Q4 		$39.7K Hold
10,000
– – 0.02% 110
2023
Q3 		$38.5K Hold
10,000
– – 0.02% 105
2023
Q2 		$59.4K Hold
10,000
– – 0.03% 115
2023
Q1 		$34.5K Hold
10,000
– – 0.01% 138
2022
Q4 		$35.1K Hold
10,000
– – 0.02% 130
2022
Q3 		$36K Hold
10,000
– – 0.02% 122
2022
Q2 		$56K Hold
10,000
– – 0.01% 178
2022
Q1 		$91K Hold
10,000
– – 0.01% 201
2021
Q4 		$111K Buy
+10,000
New +$130K 0.03% 174

Other funds holding XBIT

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LGT Fund Management's XBIT Position: Q1 2024 in Review

LGT Fund Management sold out of XBiotech (XBIT) in Q1 2024, closing a stake of 10,000 shares — an estimated $39.7K sold.

LGT Fund Management first reported a position in XBIT in Q4 2021 and held it in 9 quarters. The position peaked at $111K in Q4 2021. 46 funds tracked by Wall St. Rank hold XBIT as of Q1 2024.

  • LGT Fund Management reported no remaining XBiotech position as of Q1 2024 after selling out during the quarter.
  • LGT Fund Management sold 10,000 XBiotech shares in Q1 2024, an estimated $39.7K.
  • LGT Fund Management first reported a position in XBiotech in Q4 2021 and held it in 9 quarters.
  • LGT Fund Management's XBiotech position peaked at $111K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held XBiotech as of Q1 2024.

Based on LGT Fund Management's 13F filing for Q1 2024, filed 14 May 2024.